Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Speech"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Taltirelin Hydrate in Patients with Ataxia Due to Spinocerebellar Degeneration
Jin Whan Cho, Jee-Young Lee, Han-Joon Kim, Joong-Seok Kim, Kun-Woo Park, Seong-Min Choi, Chul Hyoung Lyoo, Seong-Beom Koh
Received May 28, 2024  Accepted October 18, 2024  Published online October 21, 2024  
DOI: https://doi.org/10.14802/jmd.24127    [Accepted]
  • 465 View
  • 85 Download
AbstractAbstract PDF
Objective
We conducted this study to assess the efficacy and safety of taltirelin hydrate (TH) in spinocerebellar degeneration (SCD).
Methods
Patients were randomly assigned to either the taltirelin group (5 mg orally, twice daily) or the control group. The primary endpoint was changes in the Korean version of Scale for the Assessment and Rating of Ataxia (K-SARA) scores at 24 weeks. The secondary endpoints include changes in the K-SARA scores at 4 and 12 weeks, the Clinical Global Impression, Five-level version of the EuroQol five-dimensional questionnaire, Tinetti balance test and gait analysis at 4, 12 and 24 weeks.
Results
A total of 149 patients (hereditary:non-hereditary = 86:63) were enrolled. There were significant differences in changes in K-SARA scores at 24 weeks from baseline between the taltirelin group and the control group (-0.51 ± 2.79 versus 0.36 ± 2.62, respectively; p = 0.0321). Of the K-SARA items, both ‘Stance’ and ‘Speech disturbance’ had significantly lower subscores in the taltirelin group as compared with the control group (-0.04 ± 0.89 versus 0.23 ± 0.79 and -0.07 ± 0.74 versus 0.18 ± 0.67; p = 0.0270 and 0.0130, respectively). But there were no significant differences in changes in other secondary efficacy outcome measures at 24 weeks from baseline between the two treatment arms (p > 0.05).
Conclusion
Clinicians might consider using TH in the treatment of ataxia due to SCD.
Case Report
Jaw Dystonia Induced by Speaking
Jong-Sam Baik, Jae-Hyeon Park, Jeong-Yeon Kim, Sang-Won Han
J Mov Disord. 2008;1(1):55-57.
DOI: https://doi.org/10.14802/jmd.08010
  • 17,203 View
  • 88 Download
  • 1 Crossref
AbstractAbstract PDF

We describe a 43-year-old housewife who presented with dysarthria suddenly because her masseter muscles contracted bilaterally, when she was speaking. Brain MRI showed focal signal change on midbrain. Jaw dystonia induced by speaking is very rare and we chose an anticholinergic medication, rather than botulinumtoxin injection. Her condition was markedly improved after medication. We suspected that her symptoms were related with focal lesion, so she had secondary jaw dystonia induced by speaking.

Citations

Citations to this article as recorded by  
  • Non-occupational task-specific masticatory dystonia
    Sang-Won Yoo, In-Seok Park, Hyung-Eun Park, Joong-Seok Kim
    Neurological Sciences.2015; 36(2): 339.     CrossRef

JMD : Journal of Movement Disorders Twitter
Close layer
TOP